BACKGROUND: Extreme prolongation or reduction of the QT interval predisposes patients to malignant ventricular arrhythmias and sudden cardiac death, but the association of variations in the QT interval within a reference range with mortality end points in the general population is unclear. METHODS: We included 7828 men and women from the Third National Health and Nutrition Examination Survey. Baseline QT interval was measured via standard 12-lead electrocardiographic readings. Mortality end points were assessed through December 31, 2006 (2291 deaths). RESULTS: After an average follow-up of 13.7 years, the association between QT interval and mortality end points was U-shaped. The multivariate-adjusted hazard ratios comparing participants at or above the 95th percentile of age-, sex-, race-, and R-R interval-corrected QT interval (≥439 milliseconds) with participants in the middle quintile (401 to <410 milliseconds) were 2.03 (95% confidence interval, 1.46-2.81) for total mortality, 2.55 (1.59-4.09) for mortality due to cardiovascular disease (CVD), 1.63 (0.96-2.75) for mortality due to coronary heart disease, and 1.65 (1.16-2.35) for non-CVD mortality. The corresponding hazard ratios comparing participants with a corrected QT interval below the fifth percentile (<377 milliseconds) with those in the middle quintile were 1.39 (95% confidence interval, 1.02-1.88) for total mortality, 1.35 (0.77-2.36) for CVD mortality, 1.02 (0.44-2.38) for coronary heart disease mortality, and 1.42 (0.97-2.08) for non-CVD mortality. Increased mortality also was observed with less extreme deviations of QT-interval duration. Similar, albeit weaker, associations also were observed with Bazett-corrected QT intervals. CONCLUSION: Shortened and prolonged QT-interval durations, even within a reference range, are associated with increased mortality risk in the general population.
BACKGROUND:Extreme prolongation or reduction of the QT interval predisposes patients to malignant ventricular arrhythmias and sudden cardiac death, but the association of variations in the QT interval within a reference range with mortality end points in the general population is unclear. METHODS: We included 7828 men and women from the Third National Health and Nutrition Examination Survey. Baseline QT interval was measured via standard 12-lead electrocardiographic readings. Mortality end points were assessed through December 31, 2006 (2291 deaths). RESULTS: After an average follow-up of 13.7 years, the association between QT interval and mortality end points was U-shaped. The multivariate-adjusted hazard ratios comparing participants at or above the 95th percentile of age-, sex-, race-, and R-R interval-corrected QT interval (≥439 milliseconds) with participants in the middle quintile (401 to <410 milliseconds) were 2.03 (95% confidence interval, 1.46-2.81) for total mortality, 2.55 (1.59-4.09) for mortality due to cardiovascular disease (CVD), 1.63 (0.96-2.75) for mortality due to coronary heart disease, and 1.65 (1.16-2.35) for non-CVD mortality. The corresponding hazard ratios comparing participants with a corrected QT interval below the fifth percentile (<377 milliseconds) with those in the middle quintile were 1.39 (95% confidence interval, 1.02-1.88) for total mortality, 1.35 (0.77-2.36) for CVD mortality, 1.02 (0.44-2.38) for coronary heart disease mortality, and 1.42 (0.97-2.08) for non-CVD mortality. Increased mortality also was observed with less extreme deviations of QT-interval duration. Similar, albeit weaker, associations also were observed with Bazett-corrected QT intervals. CONCLUSION: Shortened and prolonged QT-interval durations, even within a reference range, are associated with increased mortality risk in the general population.
Authors: J S Perkiömäki; L B Sourander; L Levomäki; I J Räihä; P Puukka; H V Huikuri Journal: Ann Noninvasive Electrocardiol Date: 2001-07 Impact factor: 1.468
Authors: Jacqueline M Dekker; Richard S Crow; Peter J Hannan; Evert G Schouten; Aaron R Folsom Journal: J Am Coll Cardiol Date: 2004-02-18 Impact factor: 24.094
Authors: Katherine A Moon; Yiyi Zhang; Eliseo Guallar; Kevin A Francesconi; Walter Goessler; Jason G Umans; Lyle G Best; Barbara V Howard; Richard B Devereux; Peter M Okin; Ana Navas-Acien Journal: Environ Pollut Date: 2018-05-26 Impact factor: 8.071
Authors: Yuko Y Inoue; Bharath Ambale-Venkatesh; Nathan Mewton; Gustavo J Volpe; Yoshiaki Ohyama; Ravi K Sharma; Colin O Wu; Chia-Ying Liu; David A Bluemke; Elsayed Z Soliman; João A C Lima; Hiroshi Ashikaga Journal: Radiology Date: 2016-10-13 Impact factor: 11.105
Authors: Roy Beinart; Yiyi Zhang; João A C Lima; David A Bluemke; Elsayed Z Soliman; Susan R Heckbert; Wendy S Post; Eliseo Guallar; Saman Nazarian Journal: J Am Coll Cardiol Date: 2014-11-10 Impact factor: 24.094
Authors: Krati Chauhan; Michael J Ackerman; Cynthia S Crowson; Eric L Matteson; Sherine E Gabriel Journal: Clin Exp Rheumatol Date: 2015-01-08 Impact factor: 4.473
Authors: C Anwar A Chahal; Joseph A Gottwald; Erik K St Louis; Jiang Xie; Peter A Brady; Rabe E Alhurani; Paul Timm; Prabin Thapa; Jay Mandrekar; Elson L So; Janet E Olson; Michael J Ackerman; Virend K Somers Journal: Heart Rhythm Date: 2021-11-11 Impact factor: 6.343
Authors: Latoya A Stewart; Gabrielle K Steinl; Bernice L Huang; Catherine McManus; James A Lee; Jennifer H Kuo; Marcella D Walker Journal: J Clin Endocrinol Metab Date: 2022-03-24 Impact factor: 5.958
Authors: Peter A Noseworthy; Gina M Peloso; Shih-Jen Hwang; Martin G Larson; Daniel Levy; Christopher J O'Donnell; Christopher Newton-Cheh Journal: Ann Noninvasive Electrocardiol Date: 2012-08-13 Impact factor: 1.468
Authors: Chaudry N Majeed; Muhammad I Ahmad; Irfan Ahsan; Muhammad A Anees; Sanjay K Maheshwari; Elsayed Z Soliman Journal: Ann Noninvasive Electrocardiol Date: 2019-09-09 Impact factor: 1.468